These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
109 related articles for article (PubMed ID: 19637088)
1. Fourth complete remission with immunosuppression withdrawal and irinotecan after both autologous and allogeneic transplants for diffuse large B cell lymphoma. Gupta NK; Barker JN; Young JW; Noy A Leuk Lymphoma; 2009 Dec; 50(12):2075-7. PubMed ID: 19637088 [No Abstract] [Full Text] [Related]
2. Comeback for the camptothecins? Kirschbaum M Leuk Lymphoma; 2009 Dec; 50(12):1914-5. PubMed ID: 19860622 [No Abstract] [Full Text] [Related]
3. [Successful salvage therapy of continuous low-dose irinotecan for a patient with relapsed and refractory diffuse large B-cell lymphoma]. Masaki Y; Sawaki T; Shimoyama K; Karasawa H; Kawanami T; Fukushima T; Kawabata H; Ogawa N; Wano Y; Sugai S; Hirose Y; Umehara H Rinsho Ketsueki; 2005 Sep; 46(9):1074-7. PubMed ID: 16440768 [TBL] [Abstract][Full Text] [Related]
4. The different roles of molecular classification according to upfront autologous stem cell transplantation in advanced-stage diffuse large B cell lymphoma patients with elevated serum lactate dehydrogenase. Kim YR; Kim SJ; Cheong JW; Yang DH; Lee H; Eom HS; Sung YO; Kim HJ; Kang HJ; Lee WS; Park Y; Yang WI; Min YH; Kim JS Ann Hematol; 2016 Sep; 95(9):1491-501. PubMed ID: 27324387 [TBL] [Abstract][Full Text] [Related]
5. A phase I trial of pharmacologic modulation of irinotecan with cyclosporine and phenobarbital. Innocenti F; Undevia SD; RamÃrez J; Mani S; Schilsky RL; Vogelzang NJ; Prado M; Ratain MJ Clin Pharmacol Ther; 2004 Nov; 76(5):490-502. PubMed ID: 15536463 [TBL] [Abstract][Full Text] [Related]
6. Diffuse large B-cell lymphoma: is there a place for autologous hematopoietic stem cell transplant in first remission in the era of chemo-immunotherapy? Nabhan C; Mehta J Leuk Lymphoma; 2012 Oct; 53(10):1859-66. PubMed ID: 22448919 [TBL] [Abstract][Full Text] [Related]
7. Allogeneic hematopoietic stem cell transplantation in patients with diffuse large B cell lymphoma relapsed after autologous stem cell transplantation: a GITMO study. Rigacci L; Puccini B; Dodero A; Iacopino P; Castagna L; Bramanti S; Ciceri F; Fanin R; Rambaldi A; Falda M; Milone G; Guidi S; Martelli MF; Mazza P; Oneto R; Bosi A; Ann Hematol; 2012 Jun; 91(6):931-9. PubMed ID: 22245922 [TBL] [Abstract][Full Text] [Related]
8. Regression of the tumor after withdrawal of cyclosporine in relapsed extranodal natural killer/T cell lymphoma following allogeneic hematopoietic stem cell transplantation. Kako S; Izutsu K; Oshima K; Sato H; Kanda Y; Motokura T; Chiba S; Kurokawa M Am J Hematol; 2007 Oct; 82(10):937-9. PubMed ID: 17663389 [TBL] [Abstract][Full Text] [Related]
9. [Autologous hematopoietic stem cell transplantation for aggressive B-cell non-Hodgkin's lymphoma]. Hirose A; Yamane T; Nakajima Y; Manabe M; Kanashima H; Hagihara K; Sakamoto E; Nakamae M; Terada Y; Kosaka S; Aoyama Y; Sakamoto C; Kumura T; Koh KR; Hirai M; Ohta K; Nakao Y; Mugitani A; Teshima H; Hino M Gan To Kagaku Ryoho; 2005 Dec; 32(13):2059-64. PubMed ID: 16352929 [TBL] [Abstract][Full Text] [Related]
11. High-dose therapy and autologous stem cell transplantation in first relapse for diffuse large B cell lymphoma in the rituximab era: an analysis based on data from the European Blood and Marrow Transplantation Registry. Mounier N; Canals C; Gisselbrecht C; Cornelissen J; Foa R; Conde E; Maertens J; Attal M; Rambaldi A; Crawley C; Luan JJ; Brune M; Wittnebel S; Cook G; van Imhoff GW; Pfreundschuh M; Sureda A; Biol Blood Marrow Transplant; 2012 May; 18(5):788-93. PubMed ID: 22005647 [TBL] [Abstract][Full Text] [Related]
12. High-dose therapy and autologous stem cell transplantation in patients with diffuse large B-cell lymphoma in first complete or partial remission. Papajik T; Raida L; Faber E; Vondrakova J; Prochazka V; Kubova Z; Skoumalova I; Jarosova M; M LK; Paucek B; Myslivecek M; Neoral C; Oral I; Jarkovsky J; Dusek L; Indrak K Neoplasma; 2008; 55(3):215-21. PubMed ID: 18348654 [TBL] [Abstract][Full Text] [Related]
13. Dendritic cells in autologous hematopoietic stem cell transplantation for diffuse large B-cell lymphoma: graft content and post transplant recovery predict survival. Dean R; Masci P; Pohlman B; Andresen S; Serafino S; Sobecks R; Kuczkowski E; Curtis J; Maciejewski J; Rybicki L; Kalaycio M; Hsi E; Theil K; Bolwell BJ Bone Marrow Transplant; 2005 Dec; 36(12):1049-52. PubMed ID: 16247431 [TBL] [Abstract][Full Text] [Related]
14. Treatment of refractory diffuse large B-cell lymphoma by chidamide combined with autologous stem cell transplantation: a case report. Wu P; Ma T; Chen Y; Wang F; Chen Y; Gao J; Zhou Z; Jia Y Anticancer Drugs; 2021 Sep; 32(8):886-889. PubMed ID: 34145178 [TBL] [Abstract][Full Text] [Related]